Search

everythinglearnresearchcommunity

for

Search:↓

Cutaneous Lymphadenoma is a unique skin tumor with specific protein markers and common gene mutations that may cause continuous cell growth.

EGF and KGF signalling prevent hair follicle formation and promote skin cell development in mice.

Blocking EGFR in skin cells doesn't majorly increase inflammation markers.

EGFR hyperactivation increases sebaceous gland size and sebum production in mice.

Understanding EGFR's role in skin is crucial for better treatments and managing side effects.

EGFR signaling is crucial for skin and hair health, and targeting it could help treat skin diseases and cancer.

Overexpressing the epigen gene in mice leads to enlarged sebaceous glands and greasy fur.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

Some vitamin D analogs can thicken skin and reduce pore size like a common acne treatment, with one analog also affecting skin growth factors.

A rare EGFR mutation in newborns leads to severe health issues and early death.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

Hydroxychloroquine may help treat benign prostatic hyperplasia by reducing inflammation and promoting cell death.

EGFR-targeting cancer drugs can cause skin rashes and other side effects.

New treatment with green tea polyphenols and nicotinamide improves skin problems from cancer therapy.

Blocking EGFR can cause skin inflammation by disrupting IL-1 signaling.

EGFR and MEK inhibitors reduce PD-L1 in hair follicles, possibly causing inflammation.

Blocking Wnt/β-catenin signaling with EGF receptor is necessary for proper hair growth.

Epiregulin can help hair grow and may be useful for treating hair loss.

EGFR signaling is essential for ear cell regeneration in both birds and mammals.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

The enzyme PA-PLA1α is important for proper hair follicle development.

Removing Gsdma1/2/3 genes reduces skin cell overgrowth by blocking a specific cell pathway.

Blocking IL-8 can reduce skin rashes from cancer treatment.

Eph/ephrin signaling is important for skin cell behavior and could be targeted to treat skin diseases.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

Targeting EGFR may help reduce hair loss from chemotherapy.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.